![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 253/07 | |
A61P 13/12 | |||
A61P 9/04 | |||
C07D 451/02 |
(11) | Number of the document | 3135668 |
(13) | Kind of document | T |
(96) | European patent application number | 15782458.2 |
Date of filing the European patent application | 2015-04-23 | |
(97) | Date of publication of the European application | 2017-03-01 |
(45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2015/062440 |
Date | 2015-04-23 |
(87) | Number | WO 2015/163427 |
Date | 2015-10-29 |
(30) | Number | Date | Country code |
2014090754 | 2014-04-24 | JP |
(72) |
USHIROGOCHI, Hideki, JP
SASAKI, Wataru, JP
ONDA, Yuichi, JP
SAKAKIBARA, Ryo, JP
AKAHOSHI, Fumihiko, JP
|
(73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku, Osaka-shi,, Osaka 541-8505,
JP
|
(54) | NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND |
NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND |